image
Healthcare - Biotechnology - NASDAQ - US
$ 0.035
-44.6 %
$ 119 K
Market Cap
0.01
P/E
INCOME STATEMENT
12 M REVENUE
0.00%
-6.9 M OPERATING INCOME
75.27%
-3.59 M NET INCOME
87.68%
EFFICIENCY
Earnings Waterfall TRACON Pharmaceuticals, Inc.
image
Revenue 12 M
Cost Of Revenue 12.3 M
Gross Profit -232 K
Operating Expenses 18.9 M
Operating Income -6.9 M
Other Expenses -3.31 M
Net Income -3.59 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012
REVENUE
Revenue 12.0 0 0.3 0 0 3.0 8.8 3.4 7.9 3.6 0 0
GROSS PROFIT
Cost Of Revenue 12.3 16 K 14 K 12 K 22 K 30.5 19.4 15.2 20.4 4.9 4.0 2.1
Gross Profit (0.2) 16 K 0.3 12 K 22 K (27.5) (10.6) (11.8) (12.5) (1.3) (4.0) (2.1)
OPERATING INCOME
Operating Expenses 18.9 27.9 28.7 16.2 22.3 37.7 27.0 29.4 31.4 9.8 7.6 5.2
Selling, General and Administrative Expenses 6.7 14.0 17.5 8.0 7.8 7.3 7.6 7.9 5.7 2.1 1.5 1.4
Research and Development Expenses 12.3 13.9 11.1 8.2 14.5 30.5 19.4 21.6 25.7 7.7 6.1 3.8
Operating Income (6.9) (27.9) (28.3) (16.2) (22.3) (34.7) (18.2) (26.0) (23.5) (6.2) (7.6) (5.2)
PRE-TAX INCOME
Interest Income Expense 7.3 1.0 0.3 0.5 0.4 0.2 0.9 1.1 0.9 0.7 30 K 0
Total Other Income 3.3 (1.2) (0.3) (0.6) (0.4) (0.2) (0.9) (1.0) (0.9) (0.6) (0.1) 0.3
Pre-Tax Income (3.6) (29.1) (28.7) (16.8) (22.7) (35.0) (19.1) (27.0) (24.4) (6.8) (7.7) (4.9)
NET INCOME
Tax Provision 0 0.2 59 K 0.6 16 K 12 K 0.8 0.9 0.9 0.6 30 K 0
Net Income (3.6) (29.3) (28.7) (17.3) (22.7) (35.0) (19.1) (27.0) (24.4) (6.8) (7.7) (4.9)
EPS 2.2 28 33.3 38.6 149 259 227 426 439 114 3.14 K 30.5